Schmitz, K. J., Callies, R., Wohlschlaeger, J., Kimmig, R., Otterbach, F., Bohr, J., Lee, H., Takeda, A., Schmid, K. W., & Baba, H. A. (2006). overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogen-activated protein kinase (ERK1/2, p38) activation or with Her-2/neu signalling pathways. Journal of clinical pathology, 59(7), 685–691. http://access.bl.uk/ark:/81055/vdc_100135129026.0x000033